Autor: "Kozlov RS" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Eremomycin pyrrolidide: a novel semisynthetic glycopeptide with improved chemotherapeutic properties
Autorzy:: Olsufyeva EN
Shchekotikhin AE
Bychkova EN
Pereverzeva ER
Treshalin ID
Mirchink EP
Isakova EB
Chernobrovkin MG
Kozlov RS
Dekhnich AV
Preobrazhenskaya MN; Pokaż więcej
Temat:: semisynthetic glycopeptides
antibacterial activity
pseudoallergic reaction
Therapeutics. Pharmacology
RM1-950
Źródło:: Drug Design, Development and Therapy, Vol Volume 12, Pp 2875-2885 (2018)
Opis pliku:: electronic resource
Relacje:: https://www.dovepress.com/eremomycin-pyrrolidide-a-novel-semisynthetic-glycopeptide-with-improve-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL:: https://doaj.org/article/4cd32c710ba24de5b3a99beca39d2e08 Link otwiera się w nowym oknie

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 2.

Tytuł:: PIN23 - Cost Implications Of Tedizolid Introduction For The Treatment Of Complicated Skin And Soft Tissue Infections In A Russian Multi-Field Hospital
Autorzy:: Belkova, YA
Rachina, SA
Kozlov, RS
Golub, AV
Portnyagina, US
Shamaeva, SH; Pokaż więcej
Źródło:: In Value in Health October-November 2017 20(9):A782-A782

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Informacja:: Dostęp do tej pozycji wymaga zalogowania się.

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 4.

Tytuł:: Genomic analysis of the international high-risk clonal lineage Klebsiella pneumoniae sequence type 395.
Autorzy:: Shaidullina ER; Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia.
Schwabe M; Pharmaceutical Microbiology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany.
Rohde T; Pharmaceutical Microbiology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany.
Shapovalova VV; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia.
Dyachkova MS; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia.
Matsvay AD; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia.
Savochkina YA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia.
Shelenkov AA; Central Research Institute of Epidemiology, Moscow, Russia.
Mikhaylova YV; Central Research Institute of Epidemiology, Moscow, Russia.
Sydow K; Pharmaceutical Microbiology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany.
Lebreton F; Multidrug-Resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, USA.
Idelevich EA; Friedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany.; Institute of Medical Microbiology, University Hospital Münster, Münster, Germany.
Heiden SE; Pharmaceutical Microbiology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany.
Becker K; Friedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany.
Kozlov RS; Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia.
Shipulin GA; Federal State Budgetary Institution 'Centre for Strategic Planning and Management of Biomedical Health Risks' of the Federal Medical Biological Agency, Moscow, Russia.
Akimkin VG; Central Research Institute of Epidemiology, Moscow, Russia.
Lalk M; Institute of Biochemistry, University of Greifswald, Greifswald, Germany.
Guenther S; Pharmaceutical Biology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany.
Zautner AE; Institute of Medical Microbiology and Hospital Hygiene, Medical Faculty, Otto-Von-Guericke University Magdeburg, Magdeburg, Germany.
Bohnert JA; Friedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, Greifswald, Germany.
Mardanova AM; Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Bouganim R; Department of Internal Medicine A, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.
Marchaim D; Infection Control Unit, Shamir (Assaf Harofeh) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Hoff KJ; Institute of Mathematics and Computer Science, University of Greifswald, Greifswald, Germany.
Schaufler K; Pharmaceutical Microbiology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany. .; Institute of Infection Medicine, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany. .
Edelstein MV; Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia.; Pokaż więcej
Źródło:: Genome medicine [Genome Med] 2023 Feb 13; Vol. 15 (1), pp. 9. Date of Electronic Publication: 2023 Feb 13.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: beta-Lactamases*/genetics
Klebsiella pneumoniae*/genetics
Genes, Bacterial*
Drug Resistance, Bacterial*/genetics
Humans ; Anti-Bacterial Agents ; Carbapenems ; Genomics ; Plasmids ; Clone Cells

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Vaccine Prophylaxis of Pneumococcal Infections in Children under Conditions of Severe Flood in the Amur River Basin.
Autorzy:: Chuchalin AG; Department of Hospital Therapy, Pediatric Faculty, Pirogov Russian National Research Medical University, Moscow 117997, Russia.
Onishchenko GG; Russian Academy of Sciences, Moscow 119991, Russia.
Kolosov VP; Laboratory of Prophylaxis of Nonspecific Pulmonary Diseases, Far Eastern Scientific Center of Physiology and Pathology of Respiration, Blagoveshchensk 675000, Russia.
Kurganova OP; The Board of the Federal Service for Surveillance in Protection of Consumer Rights and Human Well-Being in the Amur Region, Blagoveshchensk 675002, Russia.
Zaitseva TA; The Board of the Federal Service for Surveillance in Protection of Consumer Rights and Human Well-Being in Khabarovsk Territory, Khabarovsk 680009, Russia.
Manakov LG; Laboratory of Prophylaxis of Nonspecific Pulmonary Diseases, Far Eastern Scientific Center of Physiology and Pathology of Respiration, Blagoveshchensk 675000, Russia.
Kholodok GN; Research Institute of Protection of Maternity and Childhood, Far Eastern Scientific Center of Physiology and Pathology of Respiration, Khabarovsk 680022, Russia.
Perelman JM; Laboratory of Prophylaxis of Nonspecific Pulmonary Diseases, Far Eastern Scientific Center of Physiology and Pathology of Respiration, Blagoveshchensk 675000, Russia.
Kozlov RS; The Smolensk State Medical University, Smolensk 214019, Russia.
Ivakhnishina NM; Research Institute of Protection of Maternity and Childhood, Far Eastern Scientific Center of Physiology and Pathology of Respiration, Khabarovsk 680022, Russia.
Trotsenko OE; The Khabarovsk Research Institute of Epidemiology and Microbiology, Khabarovsk 680610, Russia.
Bondarenko AP; The Khabarovsk Research Institute of Epidemiology and Microbiology, Khabarovsk 680610, Russia.; Pokaż więcej
Źródło:: Interdisciplinary perspectives on infectious diseases [Interdiscip Perspect Infect Dis] 2019 Feb 18; Vol. 2019, pp. 5467275. Date of Electronic Publication: 2019 Feb 18 (Print Publication: 2019).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Erratum to: In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study.
Autorzy:: Biedenbach DJ; International Health Management Associates, Inc., Schaumburg, IL, USA. .
Badal RE; International Health Management Associates, Inc., Schaumburg, IL, USA.
Huang MY; Merck & Co. Inc., Kenilworth, NJ, USA.
Motyl M; Merck & Co. Inc., Kenilworth, NJ, USA.
Singhal PK; Merck & Co. Inc., Kenilworth, NJ, USA.
Kozlov RS; Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia.
Roman AD; Research Institute for Tropical Medicine, Manila, The Philippines.
Marcella S; Merck & Co. Inc., Kenilworth, NJ, USA.; Pokaż więcej
Źródło:: Infectious diseases and therapy [Infect Dis Ther] 2016 Sep; Vol. 5 (3), pp. 405.
Typ publikacji:: Published Erratum

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study.
Autorzy:: Biedenbach DJ; International Health Management Associates, Inc., Schaumburg, IL, USA. .
Badal RE; International Health Management Associates, Inc., Schaumburg, IL, USA.
Huang MY; Merck & Co. Inc., Kenilworth, NJ, USA.
Motyl M; Merck & Co. Inc., Kenilworth, NJ, USA.
Singhal PK; Merck & Co. Inc., Kenilworth, NJ, USA.
Kozlov RS; Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Smolensk, Russia.
Roman AD; Research Institute for Tropical Medicine, Manila, The Philippines.
Marcella S; Merck & Co. Inc., Kenilworth, NJ, USA.; Pokaż więcej
Źródło:: Infectious diseases and therapy [Infect Dis Ther] 2016 Jun; Vol. 5 (2), pp. 139-53. Date of Electronic Publication: 2016 Jun 10.
Typ publikacji:: Journal Article